BioCryst Pharma (BCRX) Reports Q4 Loss Per Share of 6c

Go back to BioCryst Pharma (BCRX) Reports Q4 Loss Per Share of 6c
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.50 -0.31 (3.16%)
Previous Close $9.81    52 Week High $10.98 
Open $9.68    52 Week Low $1.63 
Day High $9.80    P/E N/A 
Day Low $9.46    EPS $-0.68 
Volume 1,239,403